But it was reported that cancer cells could secrete hsa-miR-940 to the bone microenvironment and induce an osteogenic phenotype by targeting ARHGAP1 and FAM134A (Hashimoto et al., 2018). This evidence concerns the gene RETREG2 and cancer.